Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GSK Hopes NRT Gift Will Start Smokers Stopping Before New Year’s

This article was originally published in The Tan Sheet

Executive Summary

For the holiday season, GlaxoSmithKline added a bonus week's worth of its nicotine replacement therapy patch, NicoDerm CQ, to the two-week dose normally sold, after research pointed to increased success rates for third-week completers

You may also be interested in...



FLAVORx Hopes A Spray-Full Of Pill Glide Helps The Medicine Go Down

FLAVORx designed its flavored Pill Glide Swallowing Sprayto help consumers take difficult-to-swallow or unpleasant-tasting pills

FLAVORx Hopes A Spray-Full Of Pill Glide Helps The Medicine Go Down

FLAVORx designed its flavored Pill Glide Swallowing Sprayto help consumers take difficult-to-swallow or unpleasant-tasting pills

Senate Exempts Supplements From Redundant Regs; Suppliers Left Hanging

Food safety reform bill does not similarly exclude ingredient suppliers, who would presumably be subject to hazard analysis and critical control point-like rules.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102434

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel